Streetbeat News

Marketing

RCL

A Royal Caribbean executive announced during a conference call that due to the situation in the Red Sea, the company has rerouted some of its spring cruises. Additionally, contingency plans are in place for a few other sailings that may be impacted in the fall. The Caribbean, being the company's largest product group, represents 55% of its booked position for 2024.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 2:30 pm

FXI

RCL

A Royal Caribbean executive announced during a conference call that the company has made its return to the China market this month.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 2:13 pm

MAT

SSNLF

Mattel, Inc. (NASDAQ:MAT) has partnered with Samsung to launch its first three 24/7 Free Ad Supported Streaming (FAST) channels on Samsung TV Plus. The channels, named Barbie and Friends, Hot Wheels Action, and Mattel Jr., will feature content from Mattel's iconic brands and are set to go live later this year. This partnership marks Mattel's first foray into the FAST streaming service, aiming to engage fans with their favorite characters and storylines through Samsung's expanding content offering.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 1:04 pm

CMCSA

Comcast has announced that the Paris Olympics are set to generate the highest advertising revenue in history, with ad sales commitments already reaching $1.2 billion, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 12:51 pm

LUCY

Innovative Eyewear, Inc. has partnered with New Look Vision Group to offer its Lucyd smart eyewear in Canada. The smart frames are available on NewLook.ca and select stores in Quebec. New Look, a leading eyewear retailer with over 450 stores in the US and Canada, has been recognized as one of Canada's Best Managed Companies. This partnership allows Innovative Eyewear to introduce its products to the Canadian market, leveraging New Look's extensive retail network and award-winning retail experience.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 12:48 pm

BLCO

Bausch + Lomb Corporation announced significant results from a clinical study of a new daily nutritional supplement, Blink NutriTears, for dry eyes, meeting all primary and key secondary endpoints. The supplement, expected to launch in Q3 2024 in the U.S., showed improvements in tear production and dry eye symptoms. The study highlights the supplement's potential in addressing the growing issue of dry eyes, especially among younger demographics increasingly affected by digital device use.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 12:43 pm

CDXC

ChromaDex announced the launch of Tru Niagen at The Vitamin Shoppe, making it available at 700 retail locations and online. This expansion into a major retail chain represents a significant step for ChromaDex in increasing the accessibility and visibility of its product.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 12:42 pm

NVTS

Navitas Semiconductor (NASDAQ:NVTS) announced its participation in the China Electronic Hotspot Solutions Innovation Summit in Shenzhen on April 27th, 2024. The company will showcase its advancements in GaNFast gallium nitride (GaN) and GeneSiC silicon carbide (SiC) power semiconductors, focusing on applications in electric vehicles (EVs) such as 800 V supercharging and battery management. Navitas aims to introduce more efficient, smaller, and lighter on-board charging solutions for EVs through its keynote. The summit will feature discussions on technological trends in the new energy industry and provide a platform for Navitas to exhibit its latest products and solutions optimized for EVs.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 12:41 pm

MRNA

Moderna announced plans to present data from its respiratory portfolio, including vaccines and vaccine candidates, as well as research on cytomegalovirus, at the upcoming ESCMID Global Congress. This presentation could highlight Moderna's advancements in vaccine development and its potential impact on public health.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 11:37 am

PPBT

Purple Biotech announced that its Phase 2 study of CM24 for pancreatic cancer has been selected for a late-breaking abstract poster presentation at the ASCO 2024 Annual Meeting. This recognition could indicate significant progress in the company's cancer treatment research.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 11:25 am